Therapies for Treatment of Osteoporosis in US Women: Cost-effectiveness and Budget Impact Considerations
Osteoporosis treatment for high-risk women is cost-effective, with bisphosphonates providing the most benefit at the lowest cost.
Long-term Economic Benefits Attributed to IVF-conceived Children: A Lifetime Tax Calculation
We estimate the future net tax contributions from an IVF-conceived child to highlight that removing barriers to fertility treatments can have long-term economic benefits.
Validating the Framingham Offspring Study Equations for Predicting Incident Diabetes Mellitus
Diabetes mellitus (DM) prediction equations developed by the Framingham Offspring Study were validated, but the point score underestimated DM risk in an HMO population.
Medicine Reimbursement Recommendations in Canada, Australia, and Scotland
Pharmacoeconomic analyses appear to account for differences in recommendations made regarding public payment when national bodies consider the same drugs for the same indication.
Return on Investment for Bariatric Surgery
This editorial discusses the cost implication of bariatric surgery and whether or not return on investment analysis should be used to make coverage decisions.
Metastatic Non–Small Cell Lung Cancer: Costs Associated With Disease Progression
The incremental cost of disease progression among patients with metastatic stage IIIB or IV non-small cell lung cancer versus those without progression was $12,327 for 3 postprogression months.
A Study on the Economic Impact of Bariatric Surgery
This study analyzes the return on investment for bariatric surgery in the United States.
Complementary and Alternative Medicine in Cancer Care
Utilization Outcomes and Patient Cost Sharing
2 Clarke Drive Cranbury, NJ 08512